Giovanni Spagnolli

Geçmiş katılımlar

• 9th TPD & Induced Proximity Summit

  26–29 Oct 2026Boston, United States of America

  • KonuşmacıInducing the Selective Degradation of Cyclin D1 by Interfering with its Folding Pathway
• Oncology & Immunology Innovation Partnering & Licensing Summit

  9–10 Sept 2026Boston, United States of America

  • PanelHow Seed Stage Biotech Navigate BD Engagementİle: Yaron Sfadyah, Adam Gilbert, Nicki Thompson

Şu etkinlikteki diğer konuşmacılar: 9th TPD & Induced Proximity Summit

• Stuart Schreiber

  Professor, Harvard Medical School

• Randy Teel

  President & Chief Executive Officer, Arvinas, Inc.

• Carla Bauer

  Director, Oncology Search & Evaluation, Business Development & Licensing, Merck & Co

• Alyn Davies

  Associate Director, Medicinal Chemistry, AstraZeneca

• Jason Kantor

  Chief Business Officer, Nurix Therapeutics, Inc.

• Lauren Albrecht

  Assistant Professor, University of California, Irvine

Etkinlik sayfasında 59 konuşmacının tümünü gör

Şu etkinlikteki diğer konuşmacılar: Oncology & Immunology Innovation Partnering & Licensing Summit

• Carla Bauer

  Director, Oncology Search & Evaluation, Business Development & Licensing, Merck & Co

• Akihiro Furukawa

  Global Director, Research & Technology Search & Evaluation, Daiichi Sankyo

• Mike Jones

  Search & Evaluation Lead, GI & Inflammation, Strategy & Portfolio Development, Takeda Pharmaceutical

• Jason Kantor

  Chief Business Officer, Nurix Therapeutics, Inc.

• Nikhil Mutyal

  Head of Search and Evaluation - Respiratory and Immunology, AstraZeneca

• Dori Thomas-Karyat

  Chief Executive Officer, Synthis Therapeutics

Etkinlik sayfasında 55 konuşmacının tümünü gör